Home » GSK Acquires Rights to Santarus Omeprazole Products
GSK Acquires Rights to Santarus Omeprazole Products
Santarus has entered into agreements granting exclusive rights to GlaxoSmithKline to commercialize prescription and over-the-counter immediate-release omeprazole products for a number of markets in GSK’s international region and to distribute and sell Zegerid brand prescription products in Puerto Rico and the U.S. Virgin Islands.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May